Vaginal and Cervical Abnormalities Related to Prenatal Exposure to Diethylstilbestrol (DES)

  • Stanley J. Robboy
  • Robert E. Scully
  • Arthur L. Herbst


Primary neoplasms of any type are uncommon in the vagina, with the malignant forms accounting for less than 2% of all cancers of the female genital tract. The most common type of cancer is the squamous cell carcinoma, which usually occurs in elderly women. Clear cell adenocarcinomas, which have also been called mesonephromas and mesonephric carcinomas, are much more rare. Prior to 1970 only sporadic cases were known to have occurred in older women and only four examples had been reported in young females.12 When seven young women with clear cell adenocarcinoma of the vagina were unexpectedly encountered at the Massachusetts General Hospital between 1966 and 1969,12 a search for a common factor in their medical histories led to the association of these tumors with exposure in utero to diethylstilbestrol (DES), a synthetic, nonsteroidal estrogen that had been administered to their mothers for high-risk pregnancy.15 Later, a highly significant but less constant association of clear cell adenocarcinoma of the cervix with prenatal exposure to DES became apparent. Nonneoplastic changes of the female genital tract, including vaginal adenosis and cervical erosion, were also found not only in the great majority of the cancer patients but subsequently in a high percentage of asymptomatic young females who had been exposed prenatally to DES and the chemically related drugs, hexestrol and dienestro1.1,3,5,8–15,25,29,32,33,36


Lamina Propria Genital Tract Young Female Prenatal Exposure Female Genital Tract 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Antonioli, D. A., and Burke, L. Vaginal adenosis, analysis of 325 biopsy specimens from 100 patients. Am. J. Clin. Pathol. 64: 625, 1975.PubMedGoogle Scholar
  2. 2.
    Barber, H. R. K., and Sommers, S. C. Vaginal adenosis, dysplasia, and clear-cell adenocarcinoma after diethylstilbestrol treatment in pregnancy. Obstet. Gynecol. 43: 645, 1974.PubMedGoogle Scholar
  3. 3.
    Bibbo, M., Al-Naqeeb, M., Baccarini, I., Gill, W., Newton, M., Sleeper, K. M., Sonek, M., and Wied, G. L. Follow-up study of male and female offspring of DES-treated mothers. A preliminary report. J. Reprod. Med. 15: 29, 1975.PubMedGoogle Scholar
  4. 4.
    Blaikley, J. B., Dewhurst, D. J., Ferreira, H. P., and Lewis, T. L. T. Vaginal adenosis: Clinical and pathological features with special reference to malignant change. J. Obstet. Gynaecol. Br. Commonw. 78: 1115, 1971.PubMedCrossRefGoogle Scholar
  5. 5.
    Burke, L., Antonioli, D., Knapp, R. C., and Friedman, E. A. Vaginal adenosis. Correlation of colposcopic and pathologic findings. Obstet. Gynecol. 44: 257, 1974.Google Scholar
  6. 6.
    Fetherston, W. C. Squamous neoplasia of vagina related to DES syndrome. Am. J. Obstet. Gynecol. 122: 176, 1975.Google Scholar
  7. 7.
    Forsberg, J. G. The development of atypical epithelium in the mouse uterine cervix and vaginal fornix after neonatal oestradiol treatment. Br. J. Exp. Pathol. 50: 157, 1969.Google Scholar
  8. 8.
    Herbst, A. L., Kurman, R. J., and Scully, R. E. Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Ob-stet. Gynecol. 40: 287, 1972.Google Scholar
  9. 9.
    Herbst, A. L., Poskanzer, D. C., Robboy, S. J., Friedlander, L., and Scully, R. E. Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N. Engl. J. Med., 292: 334, 1975.PubMedCrossRefGoogle Scholar
  10. 10.
    Herbst, A. L., Robboy, S. J., MacDonald, G. J., and Scully, R. E. The effects of local progesterone on stilbestrol-associated vaginal adenosis. Am. J. Obstet. Gynecol. 118: 607, 1974.Google Scholar
  11. 11.
    Herbst, A. L., Robboy, S. J., Scully, R. E., and Poskanzer, D. C. Clear-cell adenocarcinoma of the vagina and cervix in girls: An analysis of 170 Registry cases. Am. J. Obstet. Gynecol. 119: 713, 1974.PubMedGoogle Scholar
  12. 12.
    Herbst, A. L., and Scully, R. E. Adenocarcinoma of the vagina in adolescence: A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer 25: 745, 1970.PubMedCrossRefGoogle Scholar
  13. 13.
    Herbst, A. L., Scully, R. E., and Robboy, S. J. Problems in the examination of the DES-exposed female. Obstet. Gynecol. 46: 353, 1975.PubMedGoogle Scholar
  14. 14.
    Herbst, A. L., Scully, R. E., and Robboy, S. J. Effects of maternal DES ingestion on the female genital tract. Hosp. Prac. 10: 51, 1975.Google Scholar
  15. 15.
    Herbst, A. L., Ulfelder H., and Poskanzer, D. C. Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284: 878, 1971.PubMedCrossRefGoogle Scholar
  16. 16.
    Kurman, R. J., and Scully, R. E. The incidence and histogenesis of vaginal adenosis: An autopsy study. Hum. Pathol. 5: 265, 1974.PubMedCrossRefGoogle Scholar
  17. 17.
    Lanier, A. P., Noller, K. L., Decker, D. G., Elveback, L. R., and Kurland, L. T. Cancer and stilbestrol: a follow-up of 1719 persons exposed to estrogen in utero and born in 1943–59. Mayo Clin. Proc. 48: 793, 1973.Google Scholar
  18. 18.
    Morrow, C. P., and Townsend, D. E. Management of adenosis and clear-cell adenocarcinoma of vagina and cervix. J. Reprod. Med. 15: 25, 1975.PubMedGoogle Scholar
  19. 19.
    Ng, A. B. P., Reagan, J. W., Hawliczek, S., and Wentz, W. B. Cellular detection of vaginal adenosis. Obstet. Gynecol. 46: 323, 1975.PubMedGoogle Scholar
  20. 20.
    Noller, K. L., and Fish, C. R. Diethylstilbestrol usage: Its interesting past, important present, and questionable future. Med. Clin. North Am. 58: 793, 1974.Google Scholar
  21. 21.
    Plant, A., and Dreyfuss, M. L. Adenosis of vagina and its relation to primary adenocarcinoma of vagina. Surg. Gynecol. Obstet. 71: 756, 1940.Google Scholar
  22. 22.
    Robboy, S. J., Friedlander, L., Taft, P. D., Scully, R. E., and Herbst, A. L. Vaginal and cervical cytology of 535 young females exposed prenatally to diethylstilbestrol (DES). Obstet. Gynecol., in press.Google Scholar
  23. 23.
    Robboy, S. J., Herbst, A. L., and Scully, R. E. Clear-cell adenocarcinoma of the genital tract in young females. Analysis of 37 tumors that persisted or recurred after primary therapy. Cancer 34: 606, 1974.PubMedCrossRefGoogle Scholar
  24. 24.
    Robboy, S. J., Herbst, A. L., Welch, W. R., Keh, P., and Scully, R. E. Microglandular hyperplasia (so-called “pill lesion”) arising in vaginal adenosis. Unpublished data.Google Scholar
  25. 25.
    Robboy, S. J., Scully, R. E., and Herbst, A. L. Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (DES). J. Reprod. Med. 15: 13, 1975.PubMedGoogle Scholar
  26. 26.
    Sandberg, E. C. The incidence and distribution of occult vaginal adenosis. Am. J. Obstet. Gynecol. 101: 322, 1968.PubMedGoogle Scholar
  27. 27.
    Sandberg, E. C., Danielson, R. W., and Prince, E. Benign vaginal adenosis. Obstet. Gynecol. 30: 93, 1967.Google Scholar
  28. 28.
    Scully, R. E., and Barlow, J. F. “Mesonephroma” of ovary. Tumor of Müllerian nature related to the endometrioid carcinoma. Cancer 20: 1405, 1967.PubMedCrossRefGoogle Scholar
  29. 29.
    Scully, R. E., Robboy, S. J., and Herbst, A. L. Vaginal and cervical abnormalities including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. Ann. Clin. Lab. Sci. 4: 222, 1974.Google Scholar
  30. 30.
    Silberberg, S. G. Ultrastructure and histogenesis of clear-cell carcinoma of the ovary. Am. J. Obstet. Gynecol. 115: 394, 1973.Google Scholar
  31. 31.
    Silberberg, S. G., and DeGiorgi, L. S. Clear-cell carcinoma of the endometrium. Clinical, pathologic, and ultrastructural findings. Cancer 31: 1127, 1973.CrossRefGoogle Scholar
  32. 32.
    Staff, A. Colposcopy. Clin. Obstet. Gynecol. 18: 195, 1975.Google Scholar
  33. 33.
    Staff, A., and Mattingly, R. F. Vaginal adenosis—a pre-cancerous lesion? Am. J. Obstet. Gynecol. 120: 666, 1974.Google Scholar
  34. 34.
    Taft, P. D., Robboy, S. J., Herbst, A. L., and Scully, R. E. Cytology of clear-cell adenocarcinoma of the genital tract in young females. Report of 95 cases from the Registry. Acta Cytol. 18: 279, 1974.PubMedGoogle Scholar
  35. 35.
    Takasugi, N. Morphogenesis of estrogen-independent proliferation and cornification of the vaginal epithelium of neonatally estrogenized mice. Proc. Jpn. Acad. 47: 193, 1971.Google Scholar
  36. 36.
    Ulfelder, H. Stilbestrol, adenosis, and adenocarcinoma. Am. J. Obstet. Gynecol. 117: 794, 1973.Google Scholar
  37. 37.
    Vooijs, P. G., Ng, A. B. P., and Wentz, W. B. The detection of vaginal adenosis and clear-cell carcinoma. Acta Cytol. 17: 59, 1973.PubMedGoogle Scholar
  38. 38.
    Wharton, J. T., Rutledge, F. N., Gallagher, H. S., and Fletcher, G. Treatment of clear-cell adenocarcinoma in young females. Obstet. Gynecol. 45: 365, 1975.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1977

Authors and Affiliations

  • Stanley J. Robboy
  • Robert E. Scully
  • Arthur L. Herbst

There are no affiliations available

Personalised recommendations